The use of interferon-gamma therapy in chronic granulomatous disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Recent Patents on Anti-Infective Drug Discovery

• Publication date

  2008-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/157489108786242378PMID 18991804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease

  2008cited by this paper
• Chronic Granulomatous Disease; fundamental stages in our understanding of CGD

  2006cited by this paper
• Long-Term Interferon-γ Therapy for Patients with Chronic Granulomatous Disease

  2004cited by this paper
• The large-conductance Ca2+-activated K+ channel is essential for innate immunity

  2004cited by this paper
• Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations.

  2004cited by this paper
• Interferon-γ Stimulates the Expression of the Inducible cAMP Early Repressor in Macrophages through the Activation of Casein Kinase 2

  2003cited by this paper
• PU.1 is dominant and HAF-1 supplementary for activation of the gp91phox promoter in human monocytic PLB-985 cells

  2002cited by this paper
• Cooperation of STAT-1 and IRF-1 in Interferon-γ-induced Transcription of the gp91 phox Gene*

  2002cited by this paper
• Killing activity of neutrophils is mediated through activation of proteases by K+ flux

  2002cited by this paper
• The neutrophil: function and regulation in innate and humoral immunity.

  2001cited by this paper
• Clinical aspects of chronic granulomatous disease.

  2001cited by this paper
• Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.

  2001cited by this paper
• IFN-γ Is Effective in Reducing Infections in the Mouse Model of Chronic Granulomatous Disease (CGD)

  2001cited by this paper
• Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation

  2000cited by this paper
• Tyrosine Phosphorylation of HoxA10 Decreases DNA Binding and Transcriptional Repression during Interferon γ-induced Differentiation of Myeloid Leukemia Cell Lines*

  2000cited by this paper
• Gamma Interferon Treatment of Patients with Chronic Granulomatous Disease Is Associated with Augmented Production of Nitric Oxide by Polymorphonuclear Neutrophils

  1999cited by this paper
• Effectiveness of IFN-gamma for Liver Abscesses in Chronic Granulomatous Disease

  1999cited by this paper
• PU.1, Interferon Regulatory Factor 1, and Interferon Consensus Sequence-binding Protein Cooperate to Increase gp91 phox Expression*

  1998cited by this paper
• Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components.

  1998cited by this paper
• Cellular responses to interferon-gamma.

  1997cited by this paper
• Hematologically important mutations: X-linked chronic granulomatous disease (third update).

  1997cited by this paper
• Increased Phagocyte FcγRI Expression and Improved Fcγ-Receptor–Mediated Phagocytosis After In Vivo Recombinant Human Interferon-γ Treatment of Normal Human Subjects

  1997cited by this paper
• Effect of Therapy with Recombinant Human Interferon-γ on the Release of Nitric Oxide by Neutrophils and Mononuclear Cells from Patients with Chronic Granulomatous Disease

  1996cited by this paper
• Effect of interferon‐γ, in vitro and in vivo, on mRNA levels of phagocyte oxidase components

  1996cited by this paper
• CCAAT Displacement Protein Competes with Multiple Transcriptional Activators for Binding to Four Sites in the Proximal gp91phox Promoter*

  1996cited by this paper
• Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.

  1996cited by this paper
• Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-gamma gene transfer.

  1996cited by this paper
• Characterization of three promoter elements and cognate DNA binding protein(s) necessary for IFN-gamma induction of gp91-phox transcription.

  1996cited by this paper
• A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells.

  1995cited by this paper
• Regulation of human leukocyte p21-activated kinases through G protein--coupled receptors.

  1995cited by this paper
• Function of wild-type or mutant Rac2 and Rap1a GTPases in differentiated HL60 cell NADPH oxidase activation.

  1995cited by this paper
• Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.

  1995cited by this paper
• Recombinant human interferon-gamma in patients with chronic granulomatous disease —European follow up study

  1995cited by this paper
• Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.

  1994cited by this paper
• The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases.

  1994cited by this paper
• Clinical experiences with interferon-alpha and interferon-gamma.

  1993cited by this paper
• Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease.

  1993cited by this paper
• Improvement of superoxide production in monocytes from patients with chronic granulomatous disease by recombinant cytokines

  1993cited by this paper
• Management of children on interferon therapy.

  1993cited by this paper
• Successful Interferon-γ Therapy in a Chronic Granulomatous Disease (CGD) Patient Suffering from Staphylococcus aureus Hepatic Abscess and Invasive Candida albicans Infection

  1993cited by this paper
• Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.

  1992cited by this paper
• Recombinant interferon gamma for treatment of chronic granulomatous disease and other disorders.

  1992cited by this paper
• Chronic granulomatous disease: an update and a paradigm for the use of interferon-gamma as adjunct immunotherapy in infectious diseases.

  1992cited by this paper
• Treatment of patients with chronic granulomatous disease with recombinant human interferon‐gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti‐microbial proteins

  1992cited by this paper
• Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and gamma-interferon.

  1992cited by this paper
• In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.

  1991cited by this paper
• CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.

  1991cited by this paper
• Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src.

  1990cited by this paper
• Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components.

  1990cited by this paper
• Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene.

  1990cited by this paper
• Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.

  1989cited by this paper
• Localization of the 47 kDa phosphoprotein involved in the respiratory-burst NADPH oxidase of phagocytic cells.

  1989cited by this paper
• Evaluation of a fluorochrome assay for assessing the bactericidal activity of neutrophils in human phagocyte dysfunctions.

  1989cited by this paper
• Association of a Ras-related protein with cytochrome b of human neutrophils

  1989cited by this paper
• Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease.

  1989cited by this paper
• Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.

  1989cited by this paper
• Incidence, severity, and prevention of infections in chronic granulomatous disease.

  1989cited by this paper
• Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon Gamma

  1988cited by this paper
• Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma.

  1988cited by this paper
• Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.

  1988cited by this paper
• Interferon-gamma-induced transcriptional activation is mediated by protein kinase C.

  1988cited by this paper
• Clinical features and current management of chronic granulomatous disease.

  1988cited by this paper
• Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease.

  1987cited by this paper
• Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000.

  1987cited by this paper
• Identification of a signal-transduction pathway shared by haematopoietic growth factors with diverse biological specificity.

  1987cited by this paper
• The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex

  1987cited by this paper
• Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst.

  1987cited by this paper
• Relation of cytosolic calcium to the microbicidal activation of blood monocytes by recombinant gamma interferon.

  1986cited by this paper
• Interferon-gamma modulates protein kinase C activity in murine peritoneal macrophages.

  1985cited by this paper
• Phagocytic cells in periodontal defense. Periodontal status of patients with chronic granulomatous disease of childhood.

  1985cited by this paper
• Inborn errors of oxygen-dependent microbial killing by neutrophils.

  1984cited by this paper
• Growth in patients with chronic granulomatous disease.

  1983cited by this paper
• Chronic Granulomatous Disease: A Syndrome of Phagocyte Oxidase Deficiencies

  1983cited by this paper
• Neutrophil cytochrome b in chronic granulomatous disease.

  1979cited by this paper
• Agents responsible for infection in chronic granulomatous disease of childhood.

  1975cited by this paper
• Gastrointestinal manifestations of chronic granulomatous disease.

  1973cited by this paper
• Chronic granulomatous disease: correlation between pathogenesis and clinical findings.

  1971cited by this paper
• Roentgenologic manifestations in children with a genetic defect of polymorphonuclear leukocyte function. Chronic granulomatous disease of childhood.

  1968cited by this paper
• Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

  1967cited by this paper

• "Mesenchymal stem cell-derived exosomes (MSC-exosomes) in hematology: From mechanisms to clinical breakthroughs".

  2025cites this paper
• Decreased T helper 1 cell function underlies recurrent sinopulmonary infections in the 17q12 deletion syndrome

  2025cites this paper
• Targeted treatments for immune dysregulation in inborn errors of immunity

  2024cites this paper
• The mechanism of Traditional Mongolian medicine Daruqi particles on inflammation.

  2024cites this paper
• NADPH Oxidase 2-Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function.

  2023cites this paper
• Chronic granulomatous disease

  2023cites this paper
• Immunomodulatory properties of morphine and the hypothesised role of long-term opioid use in the immunopathogenesis of tuberculosis

  2023cites this paper
• Advances in engineering and delivery strategies for cytokine immunotherapy

  2023cites this paper
• De novo mutation of CYBB gene in a boy presenting as intra-abdominal infection of Burkholderia contaminans: a case report

  2022cites this paper
• Increased Th1 Cells with Disease Resolution of Active Pulmonary Tuberculosis in Non-Atopic Patients

  2021cites this paper
• Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-trans retinoic acid-induced superoxide generating activity of U937 cells

  2021cites this paper
• Improving the function of neutrophils from chronic granulomatous disease patients using mesenchymal stem cells' exosomes.

  2020cites this paper
• Management of osteoarticular fungal infections in the setting of immunodeficiency

  2020cites this paper
• Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all-cause hospital admission

  2020cites this paper
• Comparison of the effects of adipose tissue mesenchymal stromal cell-derived exosomes with conditioned media on neutrophil function and apoptosis.

  2019cites this paper
• Type I interferons and dendritic cells in cancer immunotherapy.

  2019cites this paper
• Application of medium optimization tools for improving recombinant human interferon gamma production from Kluyveromyces lactis

  2018cites this paper
• Resveratrol strongly enhances the retinoic acid-induced superoxide generating activity via up-regulation of gp91-phox gene expression in U937 cells.

  2018cites this paper
• An Update on the Use of Immunomodulators in Primary Immunodeficiencies

  2017cites this paper
• Avaliação da formação de NETs em pacientes com deficiência de CD40 ligante.

  2017cites this paper
• Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.

  2016cites this paper
• Interferon-Gamma Improves Macrophages Function against M. tuberculosis in Multidrug-Resistant Tuberculosis Patients

  2016cites this paper
• Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem

  2016cites this paper
• IFN-lambda therapy: current status and future perspectives.

  2016cites this paper
• Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells*

  2016cites this paper
• Interferon‐gamma reduces the proliferation of M. tuberculosis within macrophages from a patient with a novel hypomorphic NEMO mutation

  2016cites this paper
• Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections: A meta-analysis of the treatments.

  2016cites this paper
• [THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DUR- ING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY].

  2016cites this paper
• Microbial Cell Factories for the Production of Recombinant Human Interferon Gamma

  2016cites this paper
• In vitro interferon γ improves the oxidative burst activity of neutrophils in patients with chronic granulomatous disease with a subtype of gp91phox deficiency

  2015cites this paper
• BAY 41-2272 activates host defence against local and disseminated Candida albicans infections

  2015cites this paper
• Función del sistema NADPH oxidasa en la formación de trampas extracelulares de los neutrófilos (NETs)

  2015cites this paper
• IFN-γ Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages

  2014cites this paper
• EFEITO DO IFN- E TNF- SOBRE A EXPRESSÃO GÊNICA DE CYBB E PROCESSAMENTO DE SEUS TRANSCRITOS

  2014cites this paper
• TH1 AND TH2 CYTOKINE GENE EXPRESSION IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS COMPARED TO CONTROLS

  2014cites this paper
• Enfermedad granulomatosa crónica

  2014cites this paper
• Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease

  2014cites this paper
• Advances and applications of molecular cloning in clinical microbiology

  2014cites this paper
• malignancies The renaissance of interferon therapy for the treatment of myeloid

  2013cites this paper
• Mechanisms of immune response regulation by innate defense regulator peptides

  2012influential citation
• Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature

  2011cites this paper
• The renaissance of interferon therapy for the treatment of myeloid malignancies.

  2011cites this paper
• Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.

  2010cites this paper
• UMA NOVA ABORDAGEM PARA O ESTUDO DOS DEFEITOS GENÉTICO-MOLECULARES DA DOENÇA GRANULOMATOSA CRÔNICA E ANÁLISE DE SUAS RELAÇÕES GENÓTIPO-FENÓTIPO

  2010cites this paper
• Sistema NADPH oxidasa: nuevos retos y perspectivas

  2010cites this paper
• Impaired macrophage function following bacterial stimulation in chronic granulomatous disease

  2009cites this paper
• Influence of signal transducer and activator of transcription-1 signaling on thyroid morphology and function.

  2009cites this paper
• Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease

  year unknowncites this paper
• International Journal of General Medicine Dovepress Hypertensive Nephropathy Treatment by Heart- Protecting Musk Pill: a Study of Anti-inflammatory Therapy for Target Organ Damage of Hypertension

  year unknowncites this paper